Advanced NanoBiomed Research Impact Factor, Indexing, Ranking 2024

Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science.The scope of Advanced NanoBiomed Research will cover the following key subject areas: Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging. Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications. Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture. Biofabrication including (bio)inks and technologies, towards the generation of functional tissues and organs. Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization. Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems.with a strong focus on applications of these fields, from bench to bedside, for the treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.

《高级纳米生物医药研究》将为前沿纳米医药、生物工程和生物材料研究提供一个开放获取的平台，旨在提升人类健康水平。该期刊将收录来自传统生物医药、生物工程和与健康相关的材料科学等传统领域的日益多学科和跨学科领域的研究成果，包括精准医疗和个性化医疗、药物递送以及由人工智能驱动的健康科学。高级纳米生物医药研究的范围将涵盖以下关键主题领域：纳米医药与纳米技术，其在药物和基因递送、诊断、治疗诊断学、光热和光动力治疗以及多模态成像中的应用。生物材料，包括水凝胶、二维材料、生物聚合物、复合材料、可生物降解材料、生物杂交和仿生学（如人工细胞、外泌体和细胞外囊泡）等，以及所有用于生物医药应用的有机和无机材料。生物界面，如抗菌表面和涂层，以及用于细胞工程、免疫工程和三维细胞培养的界面。生物制造，包括（生物）墨水和相关技术，旨在生成功能性组织和器官。组织工程和再生医学，包括支架和无支架方法，用于骨骼、韧带、肌肉、皮肤、神经、心脏组织工程和组织血管化。医疗保健应用、疾病建模和治疗设备，如诊断、芯片实验室、器官芯片、生物微机电系统、生物电子学、可穿戴设备、执行器、软体机器人以及智能药物递送系统，重点关注从实验室到病床的应用，用于治疗所有疾病和紊乱，如感染性疾病、自身免疫性疾病、心血管和代谢性疾病、神经系统疾病和癌症；包括药理学和毒理学研究。